300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 30 Life Science VC Funds & Investors in Belgium (May 2026)

The most active venture capital funds investing in Belgium Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Belgium Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
PMV
VC Fund
6 Belgium, The Netherlands, United States Series A, Seed Software, Biotechnology, Health Care $500k–$26M
Meusinvest (Noshaq)
VC Fund
3 Belgium, France, Germany Seed, Series A Health Care, Biotechnology, Medical $134k–$15M
Theodorus III
VC Fund
3 Belgium, Canada, France Seed, Series A Health Care, Life Science, Medical $2.1M–$11M
Limburgse Reconversie Maatschappij
VC Fund
3 Belgium, United States, The Netherlands Series A, Seed Information Technology, Software, Biotechnology $482k–$11M
Sambrinvest
VC Fund
3 Belgium, France, Spain Seed, Series A, Series B Biotechnology, Health Care, Information Technology $402k–$45M
Qbic Fund
VC Fund
3 Belgium Seed, Series A Biotechnology, Software, Health Care $857k–$15M
S.R.I.W.
VC Fund
3 Belgium, United States, Spain Series A, Series B Health Care, Biotechnology, Manufacturing $402k–$75M
Innovation Fund
VC Fund
2 Belgium, France, Luxembourg Seed, Series A Health Care, Manufacturing, Software $321k–$5.7M
New Science Ventures
VC Fund
2 United States, United Kingdom, Belgium Series B, Series A, Series D Biotechnology, Health Care, Therapeutics $5M–$52M
SFPI-FPIM
VC Fund
2 Belgium, United States, France Series B, Series A Health Care, Biotechnology, Medical $4.3M–$125M
Fund+
VC Fund
1 Belgium, United States, Spain Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $9.6M–$125M
Innovation Industries
VC Fund
1 The Netherlands, Belgium, United States Seed, Series B Semiconductor, Health Care, Manufacturing $2M–$17M
Vives Louvain Technology Fund
VC Fund
1 Belgium, France, United States Series A, Series B Health Care, Biotechnology, Medical $479k–$125M
UCB Ventures
VC Fund
1 United States, Belgium, Spain Series A, Series B Biotechnology, Health Care, Therapeutics $6.4M–$100M
OBI SA
VC Fund
1 Belgium Life Science, Biotechnology, Health Diagnostics
6K Venture Capital
VC Fund
1 Panama, Belgium Seed, Series A Medical, Software, Health Care
Ifoghas Investments
VC Fund
1 Belgium Series A Medical, Health Care, Life Science
Epimède SA
VC Fund
1 Belgium, The Netherlands Series B, Series C, Series D Biotechnology, Medical, Health Care
Opdorp Finance BVBA
VC Fund
1 Belgium Series A Life Science, Data Integration, Data Visualization
Fonds Vives II (University of Louvain, UCL)
VC Fund
1 Belgium, United States Series B, Series A, Seed Biotechnology, Health Care, Medical
the SRIW Life Sciences
VC Fund
1 Belgium Series A, Series B Biotechnology, Medical, Biopharma
Korys
VC Fund
1 Belgium, The Netherlands, India Series A, Series B Biotechnology, Information Technology, E-Commerce $4.6M–$21M
Merieux Developpement
VC Fund
1 France, United States, Belgium Series C, Series B Health Care, Biotechnology, Medical Device $6.4M–$56M
Seventure Partners
VC Fund
1 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $2.4M–$35M
Smedvig
VC Fund
1 Belgium Series A Medical, Health Care, Life Science
Capricorn Partners
VC Fund
1 Belgium, United States, The Netherlands Series B, Series A Biotechnology, Health Care, Software $1.6M–$41M
Qbic
VC Fund
1 Belgium Seed, Series B Health Care, AgTech, mHealth $7.3M–$12M
European Investment Bank
VC Fund
1 France, Germany, Ireland Debt Financing, Post-IPO Debt Biotechnology, Health Care, Software $6.4M–$536M
Nausicaa Ventures
VC Fund
1 Belgium Series B Software, CRM, Big Data
Nivelinvest
VC Fund
1 Belgium, United States Series A, Seed Biotechnology, iOS, Construction $6.4M–$30M
Access all 36 VC funds in Belgium Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

PMV
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 6 investments in Belgium Life Science startups, 7 in the past 12 months

Do and dare company

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Seed
  • Geography: Belgium, The Netherlands, United States

Investor stats

  • Total investments: 104
  • Round size: Seed $500k–$4.2M; Series A $2.1M–$26M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • IVEX — At IVEX, we are creating a safety co-pilot to make existing decision making platforms for autonomous driving safe. Our technology is based on years of research performed at KU Leuven University in Belgium. Our unique IP and team experience in behavior planning and functional safety enables the development of safe and reliable autonomous systems toreduce the traffic victims to zero by 2030.
  • Funkey — Kies je teambuilding uit meer dan 500 onvergetelijke activiteiten. Wij zorgen voor de volledige organisatie, incl. eventuele catering en overnachting.
  • dScribe — dScribe is your one-stop-shop to catalog, document and discover anything data-related.No more spending hours looking for the right data.No more doubting about the meaning of your KPIs.Reach the next level of data maturity by offering your users a single entry point to find, understand and access all your reports & data, no matter wherethey are stored.
Show all investments...

Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 3 investments in Belgium Life Science startups, 10 in the past 12 months

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 54
  • Round size: Seed $134k–$4M; Series A $1.1M–$15M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • RISORCE — RISORCE fills a need in Belgium for local solutions for processing tire waste while remaining dedicated to a circular economy strategy. We provide a regionally-based, technologically and environmentally sound solution.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Theodorus III
VC Fund · 3 investments in Belgium Life Science startups

Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Medical
  • Stage:Seed, Series A
  • Geography: Belgium, Canada, France

Investor stats

  • Total investments: 13
  • Round size: Seed $3.6M–$11M; Series A $2.1M–$6.4M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
  • HypnoVR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
  • Cascador Health — Cascador Health bridges the gap between sources and users of healthcare data. Using curated, validated and anonymized RWD allows healthcare providers and life science industry to gain insights and provide better care.
Show all investments...

Limburgse Reconversie Maatschappij
VC Fund · Hasselt, Limburg, Belgium · 3 investments in Belgium Life Science startups

Oxygen for growth - LRM

Show more...

Investment focus

  • Industry: Information Technology, Software, Biotechnology
  • Stage:Series A, Seed
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 81
  • Round size: Seed $482k–$2.7M; Series A $1.6M–$11M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Qviro — Compare industrial robotics and brands based on user ratings, product prices, use-cases. Reviews for Collaborative robots, Cobots, Industrial robots
  • Cumul.io — Create powerful dashboards in minutes. Share with your teams, or integrate in your platform. Drive growth in your business today!
  • MobieTrain — The mobile microlearning platform of Mobietrain improves knowledge retention with personalised, gamified learning to boost your sales.
Show all investments...

Sambrinvest
VC Fund · Gosselies, Hainaut, Belgium · 3 investments in Belgium Life Science startups

Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Belgium, France, Spain

Investor stats

  • Total investments: 30
  • Round size: Seed $531k–$903k; Series A $402k–$45M; Series B $11M–$23M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • cikisi — Specialized in Web Intelligence (collecting, searching and filtering web information). Help companies and organizations to take advantage of Web information that are relevant to their development. Develops and commercializes Cikisi WMT, a Web Intelligence Solution.
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Show all investments...

Qbic Fund
VC Fund · Belgium, Wisconsin, United States · 3 investments in Belgium Life Science startups

The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 37
  • Round size: Seed $1.3M–$5.4M; Series A $857k–$15M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • VoxelSensors — Novel sensor architecture designed for low latency and low power 3D perception.
  • Morrow Optics — Looking for the next big thing in eyewear technology? Check out Morrow's electrified progressives, also known as autofocals! These innovative glasses switch focus length with a touch of button, providing you with seamless vision from near to far. Learn more about this technology on Morrow's website.
  • Swave Photonics — Our mission is to bring the metaverse to life and enable display manufacturers and content creators to disrupt the visualization market with immersive, ultra-high-resolution, lifelike, true holographic displays.
Show all investments...

S.R.I.W.
VC Fund · Liège, Liege, Belgium · 3 investments in Belgium Life Science startups

The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A, Series B
  • Geography: Belgium, United States, Spain

Investor stats

  • Total investments: 109
  • Round size: Series A $402k–$30M; Series B $1.6M–$75M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Univercells — Univercells delivers novel biomanufacturing platforms and solutions aiming at making biologics available & affordable to all.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Show all investments...

Innovation Fund
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Belgium Life Science startups

Chemical, Advanced Materials, Cosmetics, Recycling, CleanTech, Plastics and Rubber Manufacturing, Nanotechnology, Biosciences

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Software
  • Stage:Seed, Series A
  • Geography: Belgium, France, Luxembourg

Investor stats

  • Total investments: 27
  • Round size: Seed $321k–$5.7M; Series A $2.1M–$5.4M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
  • Graftys — Graftys, an Aix-en-Provence, France-based early stage company focused on advanced bone biologics.
  • SENSE in — SENSE in manufactures monitoring solutions based on thermomechanical sensors sensitive to deformation, pressure, temperature, humidity, and more. Their solutions evaluate in real time or periodically the expected characteristics and alert on abnormal behavior, threshold overruns, and damage.
Show all investments...

New Science Ventures
VC Fund · New York, New York, United States · 2 investments in Belgium Life Science startups

New Science Ventures is a venture capital firm that focuses on investments in life sciences and information technology companies. They invest in early and late stage companies taking novel scientific approaches to address significant unmet needs, while creating order-of-magnitude improvements in performances. The company also invests in companiesusing science-based innovations to address market needs in life sciences such as pharmaceuticals, biologics, medical devices, diagnostics, and IT. The team of the company expertise in strategy and corporate planning, operations and cost management, and leadership development.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series D
  • Geography: United States, United Kingdom, Belgium

Investor stats

  • Total investments: 75
  • Round size: Series A $5.5M–$30M; Series B $8.8M–$52M; Series D $5M–$38M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Paragraf — We Work to Develop Innovative and Useful End Products from Novel Materials. Our Analogue Sensors Are Designed to Provide Accurate Field Gradient Mapping & Alignment.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • NorthSea Therapeutics — NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics. The team leverages Structurally Engineered Fatty Acid (SEFA) technology to develop novel and unique therapeutic approaches targeting metabolic, inflammatory and fibrotic diseases. The SEFA technology has generatedpipeline candidates with a broad array of inter- and independent biological effects, improving dyslipidemia, insulin resistance, hepatic inflammation and fibrosis in diverse models.
Show all investments...

SFPI-FPIM
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Belgium Life Science startups

The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A
  • Geography: Belgium, United States, France

Investor stats

  • Total investments: 36
  • Round size: Series A $4.3M–$45M; Series B $11M–$125M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Cohabs — Cohabs is a network of beautiful shared homes for nomads around the world. It provides flexible and fully furnished accommodations through a network of sustainable and community-driven shared homes. Cohabs prioritizes the experience of its members through a tech-centric and flexible process. They build a thriving community through monthly events,dinners, and other parties.
  • Univercells — Univercells delivers novel biomanufacturing platforms and solutions aiming at making biologics available & affordable to all.
  • Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Fund+
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: Belgium, United States, Spain

Investor stats

  • Total investments: 25
  • Round size: Series A $9.6M–$45M; Series B $20M–$125M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • eTheRNA immunotherapies — eTheRNA immunotherapies is developing first in class mRNA immunotherapies for the treatment of cancer and infectious diseases.
  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Show all investments...

Innovation Industries
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 1 investments in Belgium Life Science startups, 6 in the past 12 months

Innovation Industries is a Dutch venture capital fund investing in impactful deep tech, focusing on sustainability, scalability, and ESG-aligned companies.

Show more...

Investment focus

  • Industry: Semiconductor, Health Care, Manufacturing
  • Stage:Seed, Series B
  • Geography: The Netherlands, Belgium, United States

Investor stats

  • Total investments: 47
  • Round size: Seed $2M–$12M; Series B $2.9M–$17M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Aito — BRINGING SURFACES TO LIFE Integrated finger sensing & haptic technology Creating unparalleled haptics experiences Fully customisable solutions Our Propo ...
  • Axelera AI — A powerful, efficient, cost-effective, and user-friendly hardware and software AI platform to accelerate computer vision in edge devices.
  • Nearfield Instruments — Automated High-Throughput 3D Scanning Probe Metrology
Show all investments...

Vives Louvain Technology Fund
VC Fund · Louvain-la-neuve, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

Vives is an interregional seed and early stage technology multi-sector fund. The new fund, initiated by UCLouvain, is a unique European inter-university fund having access to world class innovations from leading EU top universities.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Belgium, France, United States

Investor stats

  • Total investments: 24
  • Round size: Series A $479k–$45M; Series B $4.3M–$125M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — raised $34M in 2020

Portfolio highlights

  • BOTALYS — BOTALYS uses an innovative Biomimetic Indoor Farming technology to recreate the ideal wild conditions for rare botanicals to grow in. We develop pristine & potent botanical ingredients for the Nutraceutical and Cosmetic industries.
  • Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Show all investments...

UCB Ventures
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Belgium Life Science startups

UCB Ventures is a €150 million strategic corporate venture fund

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, Belgium, Spain

Investor stats

  • Total investments: 13
  • Round size: Series A $6.4M–$55M; Series B $9.4M–$100M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Splice Bio — We are working with our proprietary platform to address key limitations of current gene therapy approaches to treat patients in need.
  • Switch Therapeutics — Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).
  • Code Biotherapeutics — Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.
Show all investments...

OBI SA
VC Fund · 1 investments in Belgium Life Science startups

OBI SA

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Health Diagnostics
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Diagenode — Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office inthe United Kingdom to better serve this specific country.Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies.Epigenetics Division
Show all investments...

6K Venture Capital
VC Fund · 1 investments in Belgium Life Science startups

6K Venture Capital operates as a venture capital firm.

Show more...

Investment focus

  • Industry: Medical, Software, Health Care
  • Stage:Seed, Series A
  • Geography: Panama, Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Rise Of Defenders — Rise of Defenders is a very interesting Metaverse NFT game, you can use your creativity and tactical thinking to become an excellent player and receive extremely attractive rewards.
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Ifoghas Investments
VC Fund · 1 investments in Belgium Life Science startups

Ifoghas Investments operates as an investment firm.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Series A
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Epimède SA
VC Fund · 1 investments in Belgium Life Science startups

Epimède SA

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series C, Series D
  • Geography: Belgium, The Netherlands

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • Imcyse — Imcyse is a clinical stage biopharmaceutical company pioneering the development of a new class of active specific immunotherapies for the treatment of severe chronic autoimmune diseases. The company’s unique technology platform allows it to locally target immune cells involved in the destruction of the diseased organ. This platform is based on theadministration of Imotopes™, which are specifically modified peptides, allowing for the generation of cytolytic CD4 T-cells, that specifically eliminate antigen-presenting cells and autoantigen specific lymphocytes. Imcyse’s approach, sustained over time, helps to prevent and treat diseases with no current therapeutic alternative and to potentially cure patients without impairing immune defense. The company has established proof of concept in several indications and has completed its first clinical trial in type 1 diabetes with promising results. Beyond type 1 diabetes, Imcyse is developing a pipeline of Imotopes™ for the treatment of several autoimmune diseases.
  • Ncardia — At Ncardia, we believe that human stem cell technology will help get better therapies to patients faster.
  • Endo Tools Therapeutics — Endo Tools Therapeutics is dedicated to the development of innovative devices that provide therapeutic interventions for gastric conditions
Show all investments...

Opdorp Finance BVBA
VC Fund · 1 investments in Belgium Life Science startups

Opdorp Finance BVBA

Show more...

Investment focus

  • Industry: Life Science, Data Integration, Data Visualization
  • Stage:Series A
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Show all investments...

Fonds Vives II (University of Louvain, UCL)
VC Fund · 1 investments in Belgium Life Science startups

Fonds Vives II (University of Louvain, UCL)

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Seed
  • Geography: Belgium, United States

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • Virovet — Antiviral drugs and thermostable vaccines for livestock
  • Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
  • ITeos Therapeutics — iTeos Therapeutics is pioneering the discovery and development of highly differentiated immuno-oncology therapeutics for cancer patients.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
the SRIW Life Sciences
VC Fund · 1 investments in Belgium Life Science startups

the SRIW Life Sciences

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Biopharma
  • Stage:Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Show all investments...

Korys
VC Fund · Halle, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

Korys is the name chosen by the Colruyt family for their investment structure. The name Korys is derived from the Latin word for hazelnut tree – Corylus - which is at the origin of the Colruyt name.Their multi-disciplinary approach enables us to create a well-balanced, diversified portfolio of listed stocks and bonds, private equity funds, anddirect participations in small and medium-sized companies. Through their investments, they aim to make a positive impact on people and the planet, while generating attractive returns. A “three P” approach (People, Planet, Profit) forms the cornerstone of their investment strategy. They invest for the long term, as they realize that it takes time to achieve the sustainable impact they are aiming for. They focus their investments in sectors in which they have built substantial expertise as a team: Cleantech, consumer goods & retail and life sciences.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, E-Commerce
  • Stage:Series A, Series B
  • Geography: Belgium, The Netherlands, India

Investor stats

  • Total investments: 13
  • Round size: Series A $4.6M–$11M; Series B $6.4M–$21M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • reMYND — Driving the development of disease-modifying treatments
  • Sahyadri Farms — Sahyadri Farms is a farmer producer and agricultural company.
  • Eneida — Operational Analytics LV Apps, software and smart sensor for LV Network Monitoring, Control, and Visibility
Show all investments...

Merieux Developpement
VC Fund · Lyon, Rhone-Alpes, France · 1 investments in Belgium Life Science startups

Mérieux Développement is specialized in Growth and Venture capital transactions in the healthcare and nutrition sectors. We support companies with products or services offering true differentiation and capacity to create substantial value over the long term. Our investment team, based in Europe and North America, brings its expertise andinternational network to help entrepreneurs disrupt and grasp substantial market opportunities. Mérieux Développement is an affiliate of Institut Mérieux, which employs approximately 17,000 employees worldwide, with consolidated revenues exceeding 2.5 billion Euros in 2017.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series C, Series B
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 39
  • Round size: Series B $6.4M–$32M; Series C $6.4M–$56M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
  • TISSIUM — TISSIUM is creating the future of tissue reconstruction. Learn more about our novel solutions based on our proprietary platform of biomorphic programmable polymers.
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Belgium Life Science startups, 7 in the past 12 months

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 175
  • Round size: Series A $2.4M–$18M; Series B $3M–$35M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Allozymes — Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzymedevelopment to the next level.
  • Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Show all investments...

Smedvig
VC Fund · Stavanger, Rogaland, Norway · 1 investments in Belgium Life Science startups

Venture Capital firm based in London. We help enable business funding though capital investment. In turn, that funds and drives business growth as exceptional speed. Visit our site to find out how our proven model of business investment can help your start up.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Series A
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Capricorn Partners
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups, 7 in the past 12 months

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 98
  • Round size: Series A $1.6M–$11M; Series B $4.5M–$41M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $93M in 2019

Portfolio highlights

  • Chainels — The tenant experience app for every property in your portfolio. Save time, gain insights and collaborate with your tenants all in one place.
  • VoxelSensors — Novel sensor architecture designed for low latency and low power 3D perception.
  • fruitcore robotics — fruitcore robotics is a robotic system that leverages intelligent software and innovative mechatronics.
Show all investments...

Qbic
VC Fund · London, England, United Kingdom · 1 investments in Belgium Life Science startups

Qbic is the result of a lot of thinking, debating and sketching of what a city hotel could be; one that breaks the rules and makes people smile.An astonishing level of change has swept through the world over the last few years. But the hotel experience is no different than it’s ever been: stuffy, over-priced and lacking soul. They’re here tochange all that. they’re curious, imaginative and friendly, and they think there are lots of people just like us seeking a hotel with personality in the middle of the city.They believe in something better than what’s currently out there. A place that celebrates life rather than sucks life out of it. A hotel that’s built on creativity and a belief that you don’t have to accept the conventional. Somewhere that sends you away with fun stories and ideas, and is easy on your pocket.

Show more...

Investment focus

  • Industry: Health Care, AgTech, mHealth
  • Stage:Seed, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 7
  • Round size: Series B $7.3M–$12M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • Cascador Health — Cascador Health bridges the gap between sources and users of healthcare data. Using curated, validated and anonymized RWD allows healthcare providers and life science industry to gain insights and provide better care.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 1 investments in Belgium Life Science startups, 56 in the past 12 months

European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, Ireland

Investor stats

  • Total investments: 202
  • Round size: Post-IPO Debt $6.4M–$536M; Debt Financing $11M–$321M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • Valmet — Valmet is the leading global developer and supplier of technologies, automation and services for the pulp, paper and energy industries.
  • CTP — CTP NV is a real estate company that owns and develops industrial and logistics parks.
  • Cofina Ivory — Cofina Ivory is a savings and credit institution that operates in the sector of mesofinance.
Show all investments...

Nausicaa Ventures
VC Fund · Mont-saint-guibert, Brabant Wallon, Belgium · 1 investments in Belgium Life Science startups

A multi-industry early stage venture capital fund Nausicaa Ventures is an early stage investment fund organisation focused on investment rounds between EUR 1 and 4 million. Nausicaa Ventures was created in 2009 by bringing together 35 private investors and selected institutional investors, such as the European Investment Fund or ING Bank, under the management of ...

Show more...

Investment focus

  • Industry: Software, CRM, Big Data
  • Stage:Series B
  • Geography: Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • NGDATA — Unleash the potential of your customer data. Our AI-driven Intelligent Engagement Platform helps you create intelligent customer journeys and meaningful digital experiences.
  • Ovizio — Ovizio Imaging Systems is an image-based sensor company transforming cell culture monitoring with innovative patented microscopy solutions.
Show all investments...

Nivelinvest
VC Fund · Louvain-la-neuve, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

Nivelinvest is a venture capital firm based in Belgium that finances seed stage investments of Small and Medium Enterprises.

Show more...

Investment focus

  • Industry: Biotechnology, iOS, Construction
  • Stage:Series A, Seed
  • Geography: Belgium, United States

Investor stats

  • Total investments: 5
  • Round size: Series A $6.4M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CluePoints — CluePoints' Risk-Based Quality Management (RBQM) Software illuminates risks that could compromise patient safety, and enables compliance with ICH E6 (R2).
  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Show all investments...

Life Science VC funding in Belgium at a glance

Stats across 21 deals from 36 investors.

36
investors
in Belgium Life Science startups
21
deals
in Belgium Life Science startups
$7.8M
median round
in Belgium Life Science startups
33%
lead investors
lead at least one round
19%
Series A
most common funding stage

Access all 36 VC funds in Belgium Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in Belgium investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 36 VC funds investing in Belgium Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists